Jaguar Health, Inc. (NASDAQ:JAGX)

About the company

Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. Its products include Canalevia, Equilevia, and Neonorm. It operates through the Human Health and Animal Health segments. The Human Health segment manufactures human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment commercializes prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.

Sector

Health Technology

Industry

Pharmaceuticals: Generic

Employees

29

CEO

Lisa A. Conte

Exchange

NASDAQ

Website

http://www.jaguar.health

$5.00M

Total Revenue

29

Employees

$6.21M

Market Capitalization

0.09

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$1M

Operating Margin (in %)

Total operating margin

$-27M

Net Margin (in %)

Total net margin

$-44M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Zoetis, Inc. ZTS 65945.10 6339.00 23.64 41.05 25.41
Mylan NV MYL 8384.71 11624.00 0.74 135.15 0.54
BridgeBio Pharma, Inc. BBIO 3821.18 41.00 10.06 -13.16 -718.08
Taro Pharmaceutical Industries Ltd. TARO 2474.94 645.00 1.18 10.26 37.88
TherapeuticsMD, Inc. TXMD 381.00 58.00 -8.82 -1.95 -333.88
LifeVantage Corp. LFVN 191.55 230.00 6.42 16.16 5.06
Abeona Therapeutics, Inc. ABEO 186.62 3.00 1.91 -1.84 75.95
Kindred Biosciences, Inc. KIN 151.71 4.00 2.53 -2.22 None
Cocrystal Pharma, Inc. COCP 62.65 2.00 2.29 -1.08 -733.84
China Pharma Holdings, Inc. CPHI 23.76 10.00 2.84 -1.10 -214.63
Jaguar Health, Inc. JAGX 6.21 5.00 4.60 0.09 -887.14

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Jaguar Health Submits Final Major Regulatory Filing for Approval of Canalevia (Crofelemer) to Treat Exercise-induced Diarrhea in Dogs

11d ago, source: YAHOO!

Working dogs, including search and rescue, military and sled dogs, often suffer diarrhea as a result of engaging in long periods of intense, off-leash exercise. "Elite athletes of all species tend to ...

BRIEF-Jaguar Health Says Oasis Capital Reported 9.99% Passive Stake In Co

5d ago, source: Reuters

OASIS CAPITAL LLC REPORTS 9.99% PASSIVE STAKE IN JAGUAR HEALTH AS OF JULY 7- SEC FILING Source text (bit.ly/3iEuBAL) Further company coverage: Our Standards:The Thomson Reuters Trust Principles.

Jaguar Health completes IND filing for Mytesi for cancer therapy‑related diarrhea

7d ago, source: Seeking Alpha

(NASDAQ:JAGX) subsidiary, Napo Pharmaceuticals has completed the filing of the IND application with the FDA for crofelemer (Mytesi) for the planned indication of prophylaxis and symptomatic relief of ...

Jaguar Health seeks US FDA’s Center for Veterinary Medicine approval for Canalevia to treat exercise-induced diarrhea in dogs

8d ago, source: Pharmabiz

Jaguar Health announced that it has submitted to the US Food and ... Jaguar's wholly owned subsidiary, Napo Pharmaceuticals, Inc. (Napo), currently markets another form of crofelemer, Mytesi, the only ...

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

23d ago, source: YAHOO!

SAN FRANCISCO, CA / ACCESSWIRE / June 19, 2020 / Jaguar Health, Inc. (JAGX) ("Jaguar" or the "Company") announced today that the Board of Directors of the Company (the "Board") adopted the Jaguar ...

Jaguar Mining Reports 23,483 Ounces Produced in Second Quarter

6d ago, source: Benzinga.com

Pilar Mine Achieves New Record Production Strong Free Cash Flow and Liquidity Operational Update on COVID-19 Action Plan TORONTO, ON / / July 7, 2020 / Jaguar ...

Driver in Seattle crash that hit 2 protesters due in court

7d ago, source: Wane

The man accused of driving a Jaguar on to a closed Seattle freeway and hitting two protesters, killing one, is scheduled to appear in court Monday.



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.